Summary Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key highlights - The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. - The Russian pharmaceuticals market had total revenues of $23.4bn in 2017, representing a compound annual growth rate (CAGR) of 13.7% between 2013 and 2017. - A key driver of growth in market is that the country has a high smoking population and high alcohol consumption, which has led to cardiovascular diseases and cancer being prominent ailments. - In Russia, the pharmaceutical market is made up of two business segments: the government procurement and the commercial market. The market is largely controlled by the commercial segment, rather than government purchasing.
Scope - Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia - Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia - Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance - Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
Reasons to buy - What was the size of the Russia pharmaceuticals market by value in 2017? - What will be the size of the Russia pharmaceuticals market in 2022? - What factors are affecting the strength of competition in the Russia pharmaceuticals market? - How has the market performed over the last five years? - Who are the top competitiors in Russia’s pharmaceuticals market?
Our reports have been used by over 10K customers, including:
117 pages •
By Infiniti Research Limited
• Dec 2018
About this market Numerous diseases and conditions are associated with pain, including arthritis, peripheral neurology, fibromyalgia and shingles. Low back pain is a common health problem in the workplace and most people are expected to experience symptoms of low back pain during their working life. Such an increase in...
300 pages •
By The Business Research Company
• Jan 2019
Gastrointestinal Drugs Market Global Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs market. Description: Where is the largest and fastest growing market for the gastrointestinal drugs? How does the market relate...
385 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Dec 2018
Pain is a debilitating condition, which can arise from arthritis, cancer, fibromyalgia and trauma, which includes neuropathic pain and nociceptive pain. This report focuses on treating various pain conditions with electrotherapy devices, ablation devices and surgical procedures. Electrotherapy devices include Spinal...
Hepatocellular Carcinoma: Competitive Landscape to 2026 Summary Hepatocellular Carcinoma (HCC) is the most common type of liver cancer.It is the sixth most common type of cancer, accounts for around 90% of primary liver cancers, and is third most common cause of cancer mortality. Hepatocellular...
RAC Alpha Serine/Threonine Protein Kinase (Protein kinase B or Protein kinase B Alpha or Proto Oncogene c Akt or RAC PK Alpha or AKT1 or EC 184.108.40.206) - Pipeline Review, H2 2018 Summary According to the recently published report ’RAC Alpha SerineThreonine Protein Kinase - Pipeline Review, H2 2018’;...
Hemophilia A - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hemophilia A - Pipeline Review, H2 2018, provides an overview of the Hemophilia A (Hematological Disorders) pipeline landscape. Hemophilia A is an X-linked, recessive...
The global healthcare BPO services is expected to reach US$ 68,198.3 Mn in 2025 from US$ 35,818.9 in 2017. The market is estimated to grow with a CAGR of 8.6% from 2018-2025. Constant changes in government regulations, mounting pressure on healthcare providers to reduce healthcare costs, rising consolidation in the healthcare BPO industry,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.